Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 10 | 4 | IMMUNOLOGY//TRANSPLANTATION//RHEUMATOLOGY | 1369268 |
| 255 | 3 | IMMUNOLOGY//CELLULAR IMMUNOLOGY//JOURNAL OF IMMUNOLOGY | 46035 |
| 2637 | 2 | CANCER IMMUNOLOGY IMMUNOTHERAPY//NEWCASTLE DISEASE VIRUS//ANTITUMOR RESISTANCE | 3739 |
| 32555 | 1 | ADRENERGIC NERVOUS SYSTEM NGF INTERACTION//BEILINSON MED SACKLER MED ONCOL//CANCER DEDIFFERENTIATION | 150 |
Terms with highest relevance score |
| rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|---|
| 1 | ADRENERGIC NERVOUS SYSTEM NGF INTERACTION | authKW | 210113 | 1% | 100% | 1 |
| 2 | BEILINSON MED SACKLER MED ONCOL | address | 210113 | 1% | 100% | 1 |
| 3 | CANCER DEDIFFERENTIATION | authKW | 210113 | 1% | 100% | 1 |
| 4 | CURRENT EVOKED POTENTIAL | authKW | 210113 | 1% | 100% | 1 |
| 5 | EARLY TUMOR GROWTH | authKW | 210113 | 1% | 100% | 1 |
| 6 | ENDOTOXIN EXTRAHEPATIC RECRUITMENT | authKW | 210113 | 1% | 100% | 1 |
| 7 | ESTUDIO TRATAMIENTO ONCOL CETRO | address | 210113 | 1% | 100% | 1 |
| 8 | EXPT MED ILEX CONICET | address | 210113 | 1% | 100% | 1 |
| 9 | HOST ANTITUMOR IMMUNE ACTIVITY | authKW | 210113 | 1% | 100% | 1 |
| 10 | HOST IMMUNOCOMPETENCE | authKW | 210113 | 1% | 100% | 1 |
Web of Science journal categories |
| chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | Oncology | 838 | 39% | 0% | 59 |
| 2 | Pediatrics | 159 | 12% | 0% | 18 |
| 3 | Surgery | 128 | 17% | 0% | 26 |
| 4 | Immunology | 81 | 13% | 0% | 19 |
| 5 | Otorhinolaryngology | 62 | 5% | 0% | 7 |
| 6 | Mathematical & Computational Biology | 40 | 3% | 0% | 5 |
| 7 | Medicine, General & Internal | 23 | 7% | 0% | 11 |
| 8 | Medicine, Research & Experimental | 13 | 5% | 0% | 7 |
| 9 | Pathology | 8 | 3% | 0% | 4 |
| 10 | Neurosciences | 5 | 6% | 0% | 9 |
Address terms |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | BEILINSON MED SACKLER MED ONCOL | 210113 | 1% | 100% | 1 |
| 2 | ESTUDIO TRATAMIENTO ONCOL CETRO | 210113 | 1% | 100% | 1 |
| 3 | EXPT MED ILEX CONICET | 210113 | 1% | 100% | 1 |
| 4 | IMMUNODIAGNOST IMMUNOCORRECT | 210113 | 1% | 100% | 1 |
| 5 | PROGRAM IMMMUNOBIOTHER Y CANC | 210113 | 1% | 100% | 1 |
| 6 | MED CHILDRENS HOSP FDN | 105056 | 1% | 50% | 1 |
| 7 | PEDIAT SURG 219 BRYANT ST | 105056 | 1% | 50% | 1 |
| 8 | AUTONOMOUS BIOTECHNOL | 70036 | 1% | 33% | 1 |
| 9 | QUEBEC INNOVAT | 52527 | 1% | 25% | 1 |
| 10 | NUCL MED ONCOL CLIN | 42021 | 1% | 20% | 1 |
Journals |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | THEORETICAL BIOLOGY AND MEDICAL MODELLING | 10131 | 3% | 1% | 5 |
| 2 | EUROPEAN PAEDIATRIC HAEMATOLOGY AND ONCOLOGY | 6776 | 1% | 3% | 1 |
| 3 | LARYNGOLOGIE RHINOLOGIE OTOLOGIE VEREINIGT MIT MONATSSCHRIFT FUR OHRENHEILKUNDE | 3611 | 3% | 0% | 4 |
| 4 | CANCER IMMUNOLOGY IMMUNOTHERAPY | 2313 | 5% | 0% | 7 |
| 5 | VOPROSY ONKOLOGII | 2157 | 3% | 0% | 4 |
| 6 | JOURNAL OF PEDIATRIC SURGERY | 2105 | 8% | 0% | 12 |
| 7 | MEDICINA-BUENOS AIRES | 1118 | 3% | 0% | 4 |
| 8 | CANCER RESEARCH | 892 | 9% | 0% | 13 |
| 9 | ARCHIV FUR GESCHWULSTFORSCHUNG | 560 | 1% | 0% | 1 |
| 10 | EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY | 443 | 1% | 0% | 2 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |